| 000 | 01871 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250516150506.0 | ||
| 264 | 0 | _c20131114 | |
| 008 | 201311s 0 0 eng d | ||
| 022 | _a1471-2172 | ||
| 024 | 7 |
_a10.1186/1471-2172-14-21 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLim, Yun-Ping | |
| 245 | 0 | 0 |
_aThe impact of polymorphisms in STAT6 on treatment outcome in HCV infected Taiwanese Chinese. _h[electronic resource] |
| 260 |
_bBMC immunology _cMay 2013 |
||
| 300 |
_a21 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAsian People _xgenetics |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGene Frequency _xgenetics |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 |
_aHaplotypes _xgenetics |
| 650 | 0 | 4 |
_aHepacivirus _xgenetics |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
| 650 | 0 | 4 |
_aLinkage Disequilibrium _xgenetics |
| 650 | 0 | 4 | _aLogistic Models |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 |
_aPolyethylene Glycols _xtherapeutic use |
| 650 | 0 | 4 |
_aPolymorphism, Single Nucleotide _xgenetics |
| 650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
| 650 | 0 | 4 |
_aRibavirin _xtherapeutic use |
| 650 | 0 | 4 |
_aSTAT6 Transcription Factor _xgenetics |
| 650 | 0 | 4 | _aTaiwan |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aHsu, Yu-An | |
| 700 | 1 | _aTsai, Kun-Hsi | |
| 700 | 1 | _aTsai, Fuu-Jen | |
| 700 | 1 | _aPeng, Cheng-Yuan | |
| 700 | 1 | _aLiao, Wen-Ling | |
| 700 | 1 | _aHung, Dong-Zong | |
| 700 | 1 | _aTien, Ni | |
| 700 | 1 | _aLin, Chien-Yih | |
| 700 | 1 | _aWan, Lei | |
| 773 | 0 |
_tBMC immunology _gvol. 14 _gp. 21 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1471-2172-14-21 _zAvailable from publisher's website |
| 999 |
_c22731471 _d22731471 |
||